Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1427373323
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
127 S. San Vicente Blvd., Suite A6600
Los Angeles, CA, 90048
Phone (310) 423-6472
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,277 services
Medicare patients, 2024
277
Average age 73
Drug cost, 2024
$822K
1,785 prescriptions
Company payments, 2025
$16K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Echo E Tan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 267 times for 150 patients. In total Echo E Tan billed 1,277 services in 28 codes, and Medicare paid $80K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 267 | 150 | $13.85 | $3,697 |
| 99215 Office E&M - Established | Facility | 226 | 134 | $111.60 | $25K |
| 99214 Office E&M - Established | Facility | 165 | 113 | $76.05 | $13K |
| 95874 Musculoskeletal | Facility | 101 | 36 | $15.56 | $1,571 |
| 95984 Electrical Nerve Conductivity | Facility | 61 | 18 | $35.69 | $2,177 |
| 99213 Office E&M - Established | Facility | 61 | 52 | $50.54 | $3,083 |
| 95983 Electrical Nerve Conductivity | Facility | 57 | 25 | $39.33 | $2,242 |
| 64616 Musculoskeletal | Facility | 52 | 16 | $110.30 | $5,736 |
| 99205 Office E&M - New | Facility | 52 | 52 | $146.37 | $7,611 |
| 95970 Electrical Nerve Conductivity | Facility | 32 | 20 | $14.13 | $452 |
| 64642 Musculoskeletal | Facility | 30 | 14 | $72.03 | $2,161 |
| 64643 Musculoskeletal | Facility | 28 | 12 | $51.06 | $1,430 |
| 64611 Musculoskeletal | Facility | 22 | 11 | $89.83 | $1,976 |
| 99421 Office/Outpatient Services | Facility | 14 | 13 | $10.99 | $154 |
| 99204 Office E&M - New | Facility | 12 | 12 | $104.87 | $1,258 |
By year: 2022 $65K for 832 services; 2023 $72K for 920 services; 2024 $80K for 1,277 services.
Medicare prescription drug claims, 2024
In 2024, the drug Echo E Tan prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 470 prescriptions and refills. In total Echo E Tan wrote 1,785 Medicare prescriptions that cost $822K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 470 | 958 | 124 | $20K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 141 | 288 | 38 | $11K |
| Amantadine Amantadine Hcl | 130 | 251 | 36 | $6,051 |
| Rytary Carbidopa/Levodopa | 125 | 163 | 18 | $110K |
| Clonazepam Generic | 109 | 150 | 18 | $1,994 |
| Gabapentin Generic | 65 | 114 | 22 | $1,416 |
| Quetiapine Fumarate Generic | 38 | 54 | 11 | $382 |
| Nourianz Istradefylline | 37 | 51 | Under 11 | $92K |
| Donepezil Hcl Generic | 34 | 42 | 12 | $213 |
| Primidone Generic | 34 | 64 | Under 11 | $647 |
| Trihexyphenidyl Hcl Generic | 32 | 65 | Under 11 | $344 |
| Entacapone Generic | 26 | 66 | Under 11 | $6,225 |
| Memantine Hcl Generic | 24 | 40 | 11 | $682 |
| Propranolol Hcl Er Propranolol Hcl | 23 | 43 | Under 11 | $708 |
| Pregabalin Generic | 22 | 48 | Under 11 | $1,712 |
Brand drugs: 263 claims; generic drugs: 1,522 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Echo E Tan $16K ($16K in general payments such as food, travel and fees) from 4 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $9,651.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.